target directory

amx0035 targets neuroprotective mechanisms through the combination of tauroursodeoxycholic acid and sodium phenylbutyrate aimed at reducing neuronal cell death and promoting cellular resilience in amyotrophic lateral sclerosis als clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.